AVVH
Get informed when a big investor buys or sells
+ FollowOvervalued by 128.1% based on the discounted cash flow analysis.
| Market cap | $3.09 Million |
|---|---|
| Enterprise Value | $4.55 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0 |
| Beta | 0.67 |
| Outstanding Shares | 966,942,572 |
| P/E Ratio | -167.16 |
|---|---|
| PEG | 85.61 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 28.82 |
| Enterprise Value to EBIT | 954.17 |
| Enterprise Value to Net Income | -246 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 12.29 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
AVVAA World Health Care Products, Inc. operates as a global biotechnology firm, specializing in natural and therapeutic personal care solutions. Its primary endeavor involves the development, manufacturing, and mass-market distribution o...